Clinical Trial

Micro Ribonucleic Acid (miRNA) Expression and Inflammatory Factors in Patients With Parkinson's and Periodontal Disease

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 1, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
MicroRNAs are important regulators of the immune and inflammatory response to bacterial pathogens during periodontal disease.The aim of this study was to evaluate the possible miRNA type for Parkinson's in saliva of orally healthy individuals.
Trial Details
NCT Number NCT07099378
Lead Sponsor Medipol University
Conditions Periodontal Diseases Inflammation
Enrollment 51 participants
Start Date 2025-08-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-01